Human Immunoglobulin (Guangdong Shuanglin)
人免疫球蛋白 (广东双林）
Report date: 2025/09/16 15:00:14
Base Information
Drug NameHuman Immunoglobulin (Guangdong Shuanglin)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2020/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangdong Shuanglin Bio-Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGuangdong Shuanglin Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A